Tag Archives: Neurocrine

Pharma Shrugged

We take issue with the commonly-held view that pushing a drug price as much as the market will bear is a fiduciary and ethical obligation: Draining every possible penny from the health care ecosystem jeopardizes the longterm health of that … Continue reading

Posted in Big Pharma, BioFollies | Tagged , , , | Leave a comment

Neurocrine and the Rogue Site

Neurocrine Biosciences has released the PhII results for NBI-98854, their VMAT2 inhibitor for Tardive Dyskinesia. The Company reported that a single site (of the eight US sites involved) threw off the overall data analysis because their AIMS testing scores did … Continue reading

Posted in Biotech | Tagged , , | Leave a comment